Biohaven Pharmaceutical Holding (BHVN) PT Lowered to $62 at SVB Leerink
Tweet
Share
E-mail
Get Alerts BHVN Hot Sheet
Price: $10.81 +6.71%
Rating Summary:
17 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Rating Summary:
17 Buy, 8 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 20 | New: 25
Join SI Premium – FREE
SVB Leerink analyst Marc Goodman lowered the price target on Biohaven Pharmaceutical Holding (NYSE: BHVN) to $62.00 (from $67.00) while maintaining an Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Upgrades Plains GP Holdings, L.P (PAGP) to Neutral
- Biohaven begins first human trial of brain-penetrant drug BHV-8100
- Nomura/Instinet Downgrades T&D Holdings Inc (8795:JP) (TDHOY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
